Author:
Norris Marie,Kanungo Shibani
Abstract
The expansion of newborn screening (NBS) encompasses a wide range of inherited metabolic disorders, including disorders of carbohydrate, lipid, and protein metabolism. Effective treatment of these disorders requires comprehensive nutrition and medical management. This review highlights the intricacies of medical nutrition therapy for several common metabolic disorders and underscores the crucial role of metabolic dietitians in managing these patients.
Subject
Cell Biology,Genetics,Molecular Biology,Molecular Medicine
Reference44 articles.
1. Almannai M, Marom R, Sutton VR. Newborn screening: A review of history, recent advancements, and future perspectives in the era of next generation sequencing. Curr Opin Pediatr. 2016; 28: 694-699.
2. Scriver CR. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants, by Robert Guthrie and Ada Susi, Pediatrics, 1963; 32: 318–343. Pediatrics. 1998; 102: 236-237.
3. Merritt JL II, Norris M, Kanungo S. Fatty acid oxidation disorders. Ann Transl Med. 2018; 6: 473.
4. Vockley J. Long-chain fatty acid oxidation disorders and current management strategies. Am J Manag Care. 2020; 26: S147-S154.
5. Schulze AS, Matern D, Hoffman GF. Newborn screening. In: Pediatric endocrinology and inborn errors of metabolism. New York: McGraw-Hill Companies; 2009. pp.17-32.